DaVita Inc. $DVA Stock Holdings Increased by LSV Asset Management

LSV Asset Management increased its holdings in DaVita Inc. (NYSE:DVA) by 1.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 936,768 shares of the company’s stock after purchasing an additional 9,739 shares during the quarter. LSV Asset Management’s holdings in DaVita were worth $106,426,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Elevation Wealth Partners LLC raised its holdings in shares of DaVita by 147.3% in the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock worth $31,000 after purchasing an additional 165 shares in the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of DaVita in the 2nd quarter worth approximately $43,000. iSAM Funds UK Ltd bought a new stake in shares of DaVita in the 3rd quarter worth approximately $46,000. Stance Capital LLC bought a new stake in shares of DaVita in the 3rd quarter worth approximately $47,000. Finally, Smartleaf Asset Management LLC raised its holdings in shares of DaVita by 34.9% in the 3rd quarter. Smartleaf Asset Management LLC now owns 452 shares of the company’s stock worth $59,000 after purchasing an additional 117 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Barclays boosted their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and boosted their price target for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. Truist Financial boosted their price target on shares of DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a report on Friday, May 8th. UBS Group boosted their price target on shares of DaVita from $190.00 to $235.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, DaVita currently has an average rating of “Hold” and an average target price of $199.17.

DaVita Price Performance

DVA stock opened at $198.39 on Friday. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $202.69. The company’s 50 day simple moving average is $162.93 and its 200-day simple moving average is $138.13. The firm has a market capitalization of $12.74 billion, a P/E ratio of 18.40, a P/E/G ratio of 0.65 and a beta of 0.84.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The business had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same quarter in the previous year, the business earned $2.00 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Sell-side analysts predict that DaVita Inc. will post 15.07 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.